CN105232745A - Infiltrative pulmonary tuberculosis complicated by tuberculous peritonitis and therapeutic thereof - Google Patents

Infiltrative pulmonary tuberculosis complicated by tuberculous peritonitis and therapeutic thereof Download PDF

Info

Publication number
CN105232745A
CN105232745A CN201510613337.4A CN201510613337A CN105232745A CN 105232745 A CN105232745 A CN 105232745A CN 201510613337 A CN201510613337 A CN 201510613337A CN 105232745 A CN105232745 A CN 105232745A
Authority
CN
China
Prior art keywords
parts
root
pulmonary tuberculosis
tuberculous peritonitis
heat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201510613337.4A
Other languages
Chinese (zh)
Inventor
吕小萍
李先强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510613337.4A priority Critical patent/CN105232745A/en
Publication of CN105232745A publication Critical patent/CN105232745A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to infiltrative pulmonary tuberculosis complicated by tuberculous peritonitis and a therapeutic thereof and relates to the technical field of medicine. For the complex disease, the infiltrative pulmonary tuberculosis complicated by tuberculous peritonitis, analysis shows that the tuberculous peritonitis has internal yin-deficiency and fire-hyperactivity, external evil and toxin, accumulation and binding of heat-poison, and extension of heat-poison to peritoneum, the tuberculous peritonitis is treated by taking a combination of herbs effective in clearing heat and toxin, dispelling wind-evil and drawing out toxin, reducing swelling and resolving mass and invigorating kidney deficiency, the herbs including 20 parts of honeysuckle herb, 20 parts of white mulberry root-bark, 15 parts of root of red-rooted Salvia, 18 parts of bidentate Achyranthes root, 15 parts of indigowood root, 20 parts of Chinese wax gourd peel, 15 parts of chicken's gizzard-membrane, 15 parts of spreading Hedyotis herb, 15 parts of weeping Forsythiae capsule, 15 parts of rehmannia root, 10 parts of seaweed, and 8 parts of kelp, pathogenic analysis is correct, the therapeutic is applied appropriately to the case, both symptoms an root causes are treated, and therapeutic effect is stable and stable.

Description

The concurrent tuberculous peritonitis of infiltrative pulmonary tuberculosis and medicine thereof
Technical field
The present invention relates to the concurrent tuberculous peritonitis of infiltrative pulmonary tuberculosis and medicine thereof, particularly with the medicine of Chinese medicine combined therapy, belong to medicine technology field.
Background technology
The concurrent tuberculous peritonitis of infiltrative pulmonary tuberculosis is exactly that pulmonary tuberculosis and peritonitis are shown effect in the lump, and peritonitis is the reason that pulmonary tuberculosis outbreak infection involves.Infiltrative pulmonary tuberculosis, common exogenous secondary type pulmonary tuberculosis, caused by namely repeatedly after tubercle bacillus affection.Minority is the tulase hidden in body, breeds when Abwehrkraft des Koepers declines, and sends out as endogenous tuberculosis, also has by primary lesion former.This kind of is more common in adult, and focus is how upper and lower at clavicle, and in the form of sheets or cotton-shaped, obscurity boundary, focus can be caseous necrosis stove, causes heavier signs of toxicity, and form caseous (Tuberculous) pneumonia, necrosis region is formed tuberculoma by after fibers encapsulation.Through the focus of suitably treatment, inflammation absorbs and dissipates, and leaves over little cheese stove, and after calcification, residual lesser tubercle focus, presents fibroid induration focus or clinical recovery.There is empty person, also can reduce through treatment absorption or close, cannot not have closedly person, also without the pathogenic bacteria of survival, be called " empty Nonsubmerged ".Infiltrative pulmonary tuberculosis is a modal type in pulmonary tuberculosis, and the performance of its symptom, sign and x-ray can have very big-difference because of the difference of the character of pathological changes, scope, developmental stage.Tuberculous peritonitis is that the peritoneum caused by tubercule bacillus is chronic, diffuse inflammation.The route of infection of primary disease can by intraperitoneal tuberculosis direct extension or hematogenous spread.The former is more common, as tuberculosis of intestine, atrophia infantum, tuberculosis of fallopian tube etc., all can be the direct primary lesion of primary disease.Common with the young and the middle aged, women is slightly more than male, is 1.2 ~ 2.0 ︰ 1.Women may be caused by pelvic tuberculosis retrograde infection more than male.
The treatment of the concurrent tuberculous peritonitis of infiltrative pulmonary tuberculosis, generally to treat pulmonary tuberculosis, treats peritonitis simultaneously.Tuberculosis chemotherapy plays a decisive role to control tuberculosis, and reasonable chemotherapy can make intralesional bacterial destruction, finally reaches recovery from illness.But there is the case of recurrence after chemotherapy recovery from illness.Active tuberculosis is the indication of chemotherapy.Then chemotherapy is not needed to scleroma focus for a long time.As for part scleroma, expectorant bacterium negative patient, observable one-phase, if x-ray patient without active performance, expectorant bacterium still negative, again without obvious tuberculosis signs of toxicity, also need not chemotherapy.Operative treatment, surgical operation is less is applied to tuberculosis treatment: when being difficult to differentiate to the tuberculoma and pulmonary carcinoma that are greater than 3cm, the one-sided fiber thick wall cavity controlled again, long-term medical treatment fail to make sputum conversion person, or one-sided Alkaline SCGE is accompanied bronchiectasis, loss of function and has spitting of blood or secondary infection person repeatedly, the lobe of the lung or full pneumonectomy can be done.Tuberculous empyema and (or) bronchopleural fistula through medical treatment invalid and accompany side active tuberculosis time, the lobe of the lung-pleurectomy should be made.Operative treatment contraindication has: bronchial mucosa active tuberculosis pathological changes, and don't within excision extension person; Systemic conditions is poor or have the full person of the obvious heart, lung, Liver and kidney function.
Summary of the invention
In order to overcome the shortcoming of Western medicine and the concurrent tuberculous peritonitis of operative treatment infiltrative pulmonary tuberculosis, this disease of traditional Chinese medical herbal treatment is utilized to receive safer, stable curative effect, although Chinese medical and herbal therapy is slow a little, Chinese medicine for old complaint, can reach the object for the treatment of both the principal and secondary aspects of a disease.With the concurrent tuberculous peritonitis of Chinese medicine viewpoint analysis infiltrative pulmonary tuberculosis, belong to inner hyperactivity of fire caused by deficiency of YIN, poison of being bewitched outward, pyretic toxicity pents up, prolong and peritoneum, treatment should with heat-clearing and toxic substances removing, dispel the wind draw out pus by applying a plaster to the affected part, the Chinese Medicine and Clavicular of dispersing swelling and dissipating binds, warming and invigorating kidney deficiency takes treatment, must receive obvious curative effect.
The concurrent tuberculous peritonitis of infiltrative pulmonary tuberculosis and medicine thereof combine by each Chinese medicine quality part ratio below: Flos Lonicerae 20 parts, Cortex Mori 20 parts, Radix Salviae Miltiorrhizae 15 parts, Radix Achyranthis Bidentatae 18 parts, Radix Isatidis 15 parts, Exocarpium Benincasae 20 parts, Endothelium Corneum Gigeriae Galli 15 parts, Herba Hedyotidis Diffusae 15 parts, Fructus Forsythiae 15 parts, 15 parts, the Radix Rehmanniae, Sargassum 10 parts, Thallus Laminariae (Thallus Eckloniae) 8 parts.
Property of medicine effect of each Chinese medicine in the concurrent tuberculous peritonitis of lower surface analysis infiltrative pulmonary tuberculosis and medicine thereof.Flos Lonicerae is the conventional Chinese medicine of heat-clearing and toxic substances removing, and not only heat clearing away is powerful, and effect of antiviral also has both simultaneously, and the disease that all pyretic toxicity pent up has lacked Flos Lonicerae, and curative effect can subtract greatly.Cortex Mori is the root bark of moraceae plants Mulberry, belongs to the good medicine that heat clearing away is eliminating evil, effect: eliminating pathogen from the lung for relieving asthma, inducing diuresis to remove edema; For lung-heat cough with asthma, the edema of the face, the diseases such as dysuria.Radix Salviae Miltiorrhizae bitter in the mouth, cold nature; GUIXIN, Liver Channel, promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, clear away heart-fire relieving restlessness, nourishing blood to tranquillize the mind; Cure mainly menoxenia, amenorrhea dysmenorrhea, lump in the abdomen, breast ventral spine pain, pyretic arthralgia pain, skin infection swells and ache, dysphoria and insomnia; Hepatosplenomegaly, angina pectoris.Radix Achyranthis Bidentatae effect: eliminating blood stasis and inducing menstruation, invigorating the liver and kidney, bone and muscle strengthening, inducing diuresis for treating stranguria syndrome, conducting blood to flow downwards; Radix Achyranthis Bidentatae had rarely both mended loose Chinese medicine of holding concurrently, and cures mainly: soreness of waist and knee joint, loss of suffering from a deficiency of the kidney.Radix Isatidis heat-clearing and toxic substances removing, removing heat from blood sore-throat relieving; For the laryngopharynx swelling and pain caused by exuberant lung-stomach heat, pharyngoxerosis, can preventing cold, health care, heat-clearing and toxic substances removing, removing heat from blood, reduce internal heat, enhancing immunity.Exocarpium Benincasae is also the good medicine-food two-purpose food of heat-clearing toxin-expelling functions, and Exocarpium Benincasae has removing heat from the liver, antiviral, anti-inflammation detumescence effect, and Exocarpium Benincasae fragrant in taste.Endothelium Corneum Gigeriae Galli energy spleen benefiting and stimulating the appetite, promoting digestion and removing stagnation, for the food stagnation distension that incoordination between the spleen and stomach causes, retention of food and drink, effect extra-heavy of Endothelium Corneum Gigeriae Galli dissipating blood stasisization knot, not only for renal calculus, swell to the gathering property of knot at other position in human body the effect tied and also have very strong eliminating stagnation to dissolve, but Endothelium Corneum Gigeriae Galli warm nature, need coordinate the Chinese medicine of heat clearing away to use.Effect of Agkistrodon house grass: heat-clearing and toxic substances removing, diuresis of blood circulation promoting; For tonsillitis, pharyngolaryngitis, urinary tract infection, pelvic inflammatory disease, appendicitis, hepatitis, bacillary dysentery, venom, tumor.Fructus Forsythiae heat clearing away, removing toxic substances, eliminating stagnation, detumescence; Control warm, erysipelas, macule, carbuncle and ulcer toxic swelling, scrofula.Radix Rehmanniae removing heat from the liver, refrigerant blood, YIN nourishing and the production of body fluid promoting.Sargassum energy Tumor suppression, health care, enhancing immunity, anticancer, antitumor, anticoagulation, lose weight, prevent thrombosis.Thallus Laminariae (Thallus Eckloniae) nature and flavor are trembled with fear, salty; Have the merit of hard masses softening and resolving, detumescencing diuresis, relaxing the bowels with lubricant drugs expectorant, bronchitis, pulmonary tuberculosis swollen for goiter, lymphonodi cervicales, cough and senile cataract etc., also try out in Therapeutic cancer clinically.
The concurrent tuberculous peritonitis of infiltrative pulmonary tuberculosis and the medicine beneficial effect of the invention thereof are: inventor is with the concurrent tuberculous peritonitis of Chinese medicine viewpoint analysis infiltrative pulmonary tuberculosis, belong to inner hyperactivity of fire caused by deficiency of YIN, to be bewitched outward poison, pyretic toxicity pents up, prolong and peritoneum, treatment should with heat-clearing and toxic substances removing, dispel the wind draw out pus by applying a plaster to the affected part, the Chinese Medicine and Clavicular of dispersing swelling and dissipating binds, warming and invigorating kidney deficiency takes treatment, old complaint analysis is correct, suits the remedy to the case, take safety, stable curative effect is remarkable.
Detailed description of the invention
The concurrent tuberculous peritonitis of infiltrative pulmonary tuberculosis and medicine thereof combine by each Chinese medicine quality part ratio below: Flos Lonicerae 20 parts, Cortex Mori 20 parts, Radix Salviae Miltiorrhizae 15 parts, Radix Achyranthis Bidentatae 18 parts, Radix Isatidis 15 parts, Exocarpium Benincasae 20 parts, Endothelium Corneum Gigeriae Galli 15 parts, Herba Hedyotidis Diffusae 15 parts, Fructus Forsythiae 15 parts, 15 parts, the Radix Rehmanniae, Sargassum 10 parts, Thallus Laminariae (Thallus Eckloniae) 8 parts.According to said medicine deal ratio, it is combine by each Chinese medicine quality below that the concurrent tuberculous peritonitis of infiltrative pulmonary tuberculosis and medicine thereof are suitable for a dosage dose that a patient takes: Flos Lonicerae 20 grams, Cortex Mori 20 grams, Radix Salviae Miltiorrhizae 15 grams, Radix Achyranthis Bidentatae 18 grams, Radix Isatidis 15 grams, Exocarpium Benincasae 20 grams, Endothelium Corneum Gigeriae Galli 15 grams, Herba Hedyotidis Diffusae 15 grams, Fructus Forsythiae 15 grams, 15 grams, the Radix Rehmanniae, Sargassum 10 grams, Thallus Laminariae (Thallus Eckloniae) 8 grams.Using method: decoct soup oral medicine soup with appropriate clear water, serious symptom person takes dose day, serve on and a week substantially eliminates symptom, within two days, can take dose after the week, serve on by fortnight above consolidate curative effect.The medication treatment time: 1 ~ 3 month.

Claims (1)

1. the concurrent tuberculous peritonitis of infiltrative pulmonary tuberculosis and medicine thereof, is characterized in that combining by each Chinese medicine quality part ratio below: Flos Lonicerae 20 parts, Cortex Mori 20 parts, Radix Salviae Miltiorrhizae 15 parts, Radix Achyranthis Bidentatae 18 parts, Radix Isatidis 15 parts, Exocarpium Benincasae 20 parts, Endothelium Corneum Gigeriae Galli 15 parts, Herba Hedyotidis Diffusae 15 parts, Fructus Forsythiae 15 parts, 15 parts, the Radix Rehmanniae, Sargassum 10 parts, Thallus Laminariae (Thallus Eckloniae) 8 parts.
CN201510613337.4A 2015-09-24 2015-09-24 Infiltrative pulmonary tuberculosis complicated by tuberculous peritonitis and therapeutic thereof Withdrawn CN105232745A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510613337.4A CN105232745A (en) 2015-09-24 2015-09-24 Infiltrative pulmonary tuberculosis complicated by tuberculous peritonitis and therapeutic thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510613337.4A CN105232745A (en) 2015-09-24 2015-09-24 Infiltrative pulmonary tuberculosis complicated by tuberculous peritonitis and therapeutic thereof

Publications (1)

Publication Number Publication Date
CN105232745A true CN105232745A (en) 2016-01-13

Family

ID=55030740

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510613337.4A Withdrawn CN105232745A (en) 2015-09-24 2015-09-24 Infiltrative pulmonary tuberculosis complicated by tuberculous peritonitis and therapeutic thereof

Country Status (1)

Country Link
CN (1) CN105232745A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104306837A (en) * 2014-08-06 2015-01-28 张立梅 Baibei anti-tuberculosis pill for treating pulmonary tuberculosis, tuberculous pleuritis, peritonitis, empyema and bronchopleural fistula

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104306837A (en) * 2014-08-06 2015-01-28 张立梅 Baibei anti-tuberculosis pill for treating pulmonary tuberculosis, tuberculous pleuritis, peritonitis, empyema and bronchopleural fistula

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
乐强: "《千家秒方与临床应用》", 30 April 2004, 青海人民出版社 *

Similar Documents

Publication Publication Date Title
CN102631413B (en) Chinese medicinal composition for treating acne
CN103520670A (en) Traditional Chinese medicine composition for treating neonatal jaundice
CN103100003B (en) Traditional Chinese medicine composition for treating acute gouty arthritis
CN104721665A (en) Traditional Chinese medicine composition for treating cough and preparation method thereof
CN103251889A (en) Traditional Chinese medicine composition for treating agalactia
CN105796891A (en) Traditional Chinese medicinal composition for treating epigastric pain
CN102091279A (en) Traditional Chinese medicine composition for treating duodenal ulcer
CN105232745A (en) Infiltrative pulmonary tuberculosis complicated by tuberculous peritonitis and therapeutic thereof
CN104623410A (en) Traditional Chinese medicine for treating radiation pneumonitis
CN102940806B (en) Chinese medicinal composition for treating hyperlipidemia
CN104001100A (en) Traditional Chinese medicine composition for treating PICC (Peripherally Inserted Central Catheter) phlebothrombosis and preparation method of traditional Chinese medicine composition
CN103893432A (en) Pharmaceutical composition for treating fracture and soft tissue injury and preparation method of pharmaceutical composition
CN103933299A (en) Chinese herbal preparation for treating rheumatic arthritis
CN104383355A (en) Chinese herba preparation for treating chronic hypertrophic rhinitis
CN105194241A (en) Traditional Chinese medicine preparation for treating neurasthenia and preparation method
CN104873862A (en) Traditional Chinese medicine composition for treating chronic pharyngitis
CN103933139A (en) Traditional Chinese medicinal preparation for effectively treating flat wart
CN104523868A (en) Medicine for treating blood stasis stagnating syndrome
CN104352773A (en) Traditional Chinese medicine preparation for treating chronic bronchitis and bronchial asthma
CN102284014B (en) Traditional Chinese medicine composition for treating mastalgia
CN103656349A (en) Traditional Chinese medicine complexing agent used for treatment of acne vulgaris
CN106309988A (en) Medicinal decoction for treating wind-heat cold dampness syndrome and preparation method thereof
CN106237261A (en) A kind of for decoction medicine treating gastric cancer and preparation method thereof
CN107349357A (en) A kind of pill medicine and preparation method for treating chronic prostatitis
CN105726915A (en) Traditional Chinese medicine composition for treating liver-qi stagnation type mastitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20160113